home All News open_in_new Full Article

Novo licenses Chinese biotech's obesity drug candidate for up to $2 billion

Novo licenses Chinese biotech's obesity drug candidate for up to $2 billion  Reuters


today 4 d. ago attach_file Economics

attach_file Politics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Politics
attach_file Events
attach_file Events
attach_file Society


ID: 2581662103
Add Watch Country

arrow_drop_down